Elisabetta Rossi






Elisabetta Rossi

Date of birth

25 March 1975

Place of birth

Camposampiero (PD)

Academic position

Technician - DOSS University of Padova

Institutional authorized official

prof. Zaccaria

Bachelor’s degree

Biological Science at the University of Padova, with marks 102/110 cum laude (2001)

Postgraduate studies

Clinical Pathology at the Medical School of the University of Padova, with marks 70/70 cum laude (2006)

Professional positions:

Technician at the at Oncology Section of the DOSS-University of Padova (since 2002).

Scientific activity:

13 publications in peer-reviewed journals; h-index 10

Research interests:


Physiology and pathology of the immune system;


Immunologic alterations during HIV infection;


Predictive value and biologic significance of Circulating Tumor Cells (CTC) in solid tumors.

Visiting fellowships:

2012: LLP-LifelongLearningProgramme Erasmus - Staff Training

at the University of Twente (NL) - Department of Medical Cell Biophysics, headed prof. Leon WMM Terstappen



2004-2006: She has collaborated in the study " B cell deregulation during HIV infection: role of the HIV-1 matrix protein p17" (ISS–AIDS Project: # 40G.60, PI Rita Zamarchi).

2008-today: She collaborates in the Project Ricerca Sanitaria Finalizzata 2008 conducted at IOV-IRCCS of Padova (PI prof. A. Amadori), entitled " Predictive value and biologic significance of circulating tumour cells (CTC) in solid tumors".

2009-today: She collaborates in the Task 4 ("Characterization of circulating tumor cells in breast and ovary cancer ") of the "Progetto Oncologico di Medicina Molecolare: i tumori femminili" conducted at IOV-IRCCS of Padova (PI prof. P. Zanovello).

2009-today: She collaborates in the Project "construction of regulatory networks of cancer by integrating gene expression, alternative splicing and microRNA expression data" (PI prof. D.Nitti DOSS Padova), funded by AIRC.

2010-today: She collaborates in the Task 2 ("Evaluation of the CTC", coordinator Rita Zamarchi, IOV-IRCCS of Padova) of the Project " Metformin plus chemotherapy in advanced breast cancer: prognostic and predictive tools" (PI A. Gennari, IST Genova), funded by AIRC.

2011-today: She collaborates in the study " Predictive value of Circulating Melanoma Cells (CMC) in anti-BRAF treated Metastatic Melanoma" (coordinator Rita Zamarchi, IOV-IRCCS of Padova) of the ACC (Alleanza Contro il Cancro)/Project 3 (PI P. Zanovello, University od Padova).

2012-today: She collaborates in the:

 Specific Programme “Cooperation” – Theme "Health"

Call identifier: FP7-HEALTH-2012-INNOVATION-1

Proposal No: 305341-2

Acronym: CTCtrap

2012-today: She coordinates as PI the study:

Individualized treatment of patients with advanced NSCLC: potential application for circulating Tumor Cells (CTC) molecular and phenotypical profiling



Project Code: GR-2010-2303193



Amadori A, Rossi E, Zamarchi R, Carli P, Pastorelli D, Jirillo A: Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions, Oncology 2009, 76:375-386


Antonello J, Rossi E, Basso U, Facchinetti A, Zagonel V, Swennenhuis JF, Terstappen LW, Amadori A, Zamarchi R: FEASIBILITY OF GENETIC ABERRATIONS ANALYSIS IN THE CIRCULATING TUMOR CELLS (CTCS), Annals of Oncology 2012, 23:91-91


Basso U, Rossi E, Indraccolo S, Barile C, Sava T, Aieta M, Brunello A, Jirillo A, Amadori A, Zamarchi R: Do circulating tumor cells (CTCs) correlate with response to first-line sunitinib in metastatic renal carcinoma?, Ejc Supplements 2009, 7:428-428


Ciminale V, Silic-Benussi M, D'Agostino DM, Cavallari I, Zorzan T, Rosato A, Willems L, Lairmore MD, Chieco-Bianchi L, Rossi E: Impact of the HTLV-1 p13II protein on cell growth and tumorigenesis, Aids Research and Human Retroviruses 2003, 19:S22-S22


Colombrino E, Rossi E, Ballon G, Terrin L, Indraccolo S, Chieco-Bianchi L, De Rossi A: Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells, Experimental Cell Research 2004, 295:539-548


Conteduca V, Zamarchi R, Rossi E, Condelli V, Troiani L, Aieta M: Circulating tumor cells: utopia or reality?, Future Oncology 2013, 9:1337-1352


Favaro E, Nardo G, Persano L, Masiero M, Moserle L, Zamarchi R, Rossi E, Esposito G, Plebani M, Sattler U, Mann T, Mueller-Klieser W, Ciminale V, Amadori A, Indraccolo S: Hypoxia inducible factor-1 alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death, American Journal of Pathology 2008, 173:1186-1201


Jirillo A, Carli P, Zamarchi R, Rossi E, Amadori A: CIRCULATING TUMOR CELLS IN BREAST CANCER, Annals of Oncology 2008, 19:253-253


Mandruzzato S, Rossi E, Bernardi F, Tosello V, Macino B, Basso G, Chiarion-Sileni V, Rossi CR, Montesco C, Zanovello P: Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient, Journal of Immunology 2002, 169:4017-4024


Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V, Zamarchi R, Corradin A, Minuzzo S, Rossi E, Basso G, Amadori A: The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects, Cancer Research 2008, 68:5658-5668


Nardo G, Favaro E, Curtarello M, Moserle L, Zulato E, Persano L, Rossi E, Esposito G, Crescenzi M, Casanovas O, Sattler U, Mueller-Klieser W, Biesalski B, Thews O, Canese R, Iorio E, Zanovello P, Amadori A, Indraccolo S: Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization, Cancer Research 2011, 71:4214-4225


Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P: Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis, BMC Genomics 2013, 14:


Rossi E, Basso U, Celadin R, Zilio F, Pucciarelli S, Aieta M, Barile C, Sava T, Bonciarelli G, Tumolo S, Ghiotto C, Magro C, Jirillo A, Indraccolo S, Amadori A, Zamarchi R: M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis, Clinical Cancer Research 2010, 16:5233-5243


Rossi E, Facchinetti A, Grassi A, Rossi CR, Stragliotto S, Pigozzo J, Chiarion-Sileni V, Amadori A, Zanovello P, Zamarchi R: Potential applications of circulating melanoma cells (CMCs) expressing gamma-H2AX, Journal of Clinical Oncology 2013, 31:


Rossi E, Facchinetti A, Zamarchi R: Customizing CellSearch platform, Cytometry Part A 2013, 83A:595-598


Rossi E, Fassan M, Aieta M, Zilio F, Celadin R, Borin M, Grassi A, Troiani L, Basso U, Barile C, Sava T, Lanza C, Miatello L, Jirillo A, Rugge M, Indraccolo S, Cristofanilli M, Amadori A, Zamarchi R: Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer, British Journal of Cancer 2012, 107:1286-1294


Silic-Benussi M, Cavallari L, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, Ciminale V: Suppression of tumor growth and cell proliferation by p13(II), a mitochondrial protein of human T cell leukemia virus type 1, Proc Natl Acad Sci U S A 2004, 101:6629-6634


Tramentozzi E, Zamarchi R, Pagetta A, Brunati AM, Rossi E, Tibaldi E, Finotti P: Effects of glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells, Cell Stress & Chaperones 2011, 16:329-338


Tramentozzi E, Zamarchi R, Rossi E, Pagetta A, Frigo G, Finotti P: Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) in allergic subjects, Molecular and Cellular Biochemistry 2012, 365:47-52


Vincenzi B, Rossi E, Zoccoli A, Iuliani M, Pantano F, Frezza AM, Silletta M, Tonini G, Zamarchi R, Santini D: CIRCULATING TUMOR CELLS IN SOFT TISSUE SARCOMAS PATIENTS, Annals of Oncology 2012, 23:489-489


Zovato S, Opocher G, Rossi E, Indraccolo S, Amadori A, Pastorelli D, Lombardi G, Anglani M, Zamarchi R: Predictive value and biologic significance of circulating tumor cells (CTC) in sporadic and von hippel lindau (VHL) renal cancer, Ejc Supplements 2009, 7:436-437


Zovato S, Rossi E, Indraccolo S, Anglani M, Pastorelli D, Lombardi G, Opocher G, Amadori A, Zamarchi R: PREDICTIVE VALUE AND BIOLOGIC SIGNIFICANCE OF CIRCULATING TUMOR CELLS (CTC) IN SPORADIC AND VON HIPPEL LINDAU (VHL) RENAL CANCER, Annals of Oncology 2009, 20: